SLC25A19 deficiency and bilateral striatal necrosis with polyneuropathy: a new case and review of the literature
- PMID: 33544541
- DOI: 10.1515/jpem-2020-0139
SLC25A19 deficiency and bilateral striatal necrosis with polyneuropathy: a new case and review of the literature
Abstract
Objectives: Biallelic mutations in the SLC25A19 gene impair the function of the thiamine mitochondrial carrier, leading to two distinct clinical phenotypes. Homozygosity for the c.530G > C mutation is invariably associated to Amish lethal microcephaly. The second phenotype, reported only in 8 patients homozygous for different non-Amish mutations (c.373G > A, c.580T > C, c.910G > A, c.869T > A, c.576G > C), is characterized by bilateral striatal necrosis and peripheral polyneuropathy. We report a new patient with the non-Amish SLC25A19 phenotype showing compound heterozygosity for the new variant c.673G > A and the known mutation c.373G > A.
Case presentation: The natural history of non-Amish SLC25A19 deficiency is characterized by acute episodes of fever-induced encephalopathy accompanied by isolated lactic acidosis and Leigh-like features at magnetic resonance imaging (MRI). Acute episodes are prevented by high-dose thiamine treatment (600 mg/day). As shown in the new case, both mild clinical signs and basal ganglia involvement can precede the acute encephalopathic onset of the disease, potentially allowing treatment anticipation and prevention of acute brain damage. Peripheral axonal neuropathy, observed in 7 out of 9 patients, is not improved by thiamine therapy. In two early treated patients, however, peripheral neuropathy did not occur even on long-term follow-up, suggesting a potential preventive role of treatment anticipation also at the peripheral level.
Conclusions: Non-Amish SLC25A19 deficiency is an extra-rare cause of Leigh syndrome responsive to thiamine treatment. Ex adiuvantibus thiamine treatment is mandatory in any patient with Leigh-like features.
Keywords: SLC25A19; leigh syndrome; mitochondrial diseases; thiamine.
© 2020 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Bilateral Striatal Necrosis with Polyneuropathy with a Novel SLC25A19 (Mitochondrial Thiamine Pyrophosphate Carrier OMIMI*606521) Mutation: Treatable Thiamine Metabolic Disorder-A Report of Two Indian Cases.Neuropediatrics. 2019 Oct;50(5):313-317. doi: 10.1055/s-0039-1693148. Epub 2019 Jul 11. Neuropediatrics. 2019. PMID: 31295743
-
SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis.Ann Neurol. 2009 Sep;66(3):419-24. doi: 10.1002/ana.21752. Ann Neurol. 2009. PMID: 19798730
-
Functional analysis of the third identified SLC25A19 mutation causative for the thiamine metabolism dysfunction syndrome 4.J Hum Genet. 2019 Nov;64(11):1075-1081. doi: 10.1038/s10038-019-0666-5. Epub 2019 Sep 11. J Hum Genet. 2019. PMID: 31506564 Free PMC article.
-
Clinical and genetic studies of thiamine metabolism dysfunction syndrome-4: case series and review of the literature.Clin Dysmorphol. 2022 Jul 1;31(3):125-131. doi: 10.1097/MCD.0000000000000411. Epub 2022 Jan 31. Clin Dysmorphol. 2022. PMID: 35102031 Free PMC article. Review.
-
Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.J Inherit Metab Dis. 2019 Jul;42(4):581-597. doi: 10.1002/jimd.12125. Epub 2019 Jun 24. J Inherit Metab Dis. 2019. PMID: 31095747 Review.
Cited by
-
The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.Orphanet J Rare Dis. 2022 Sep 2;17(1):335. doi: 10.1186/s13023-022-02495-3. Orphanet J Rare Dis. 2022. PMID: 36056365 Free PMC article. Review.
-
SLC25A19 drives colorectal cancer progression by regulating p53.Cancer Med. 2024 Sep;13(18):e70253. doi: 10.1002/cam4.70253. Cancer Med. 2024. PMID: 39344563 Free PMC article.
-
Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndrome.JCI Insight. 2022 Mar 8;7(5):e156522. doi: 10.1172/jci.insight.156522. JCI Insight. 2022. PMID: 35050903 Free PMC article.
References
-
- Manzetti, S, Zhang, J, van der Spoel, D. Thiamin function, metabolism, uptake, and transport. Biochemistry 2014;53:821–35. https://doi.org/10.1016/10.1021/bi401618y.
-
- Mkrtchyan, G, Aleshin, V, Parkhomenko, Y, Kaehne, T, Di Salvo, ML, Parroni, A, et al.. Molecular mechanisms of the non-coenzyme action of thiamin in brain: biochemical, structural and pathway analysis. Sci Rep 2015;5:12583. https://doi.org/10.1016/10.1038/srep12583.
-
- Marcé-Grau, A, Martí-Sánchez, L, Baide-Mairena, H, Ortigoza-Escobar, JD, Pérez-Dueñas, B. Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis 2019;42:581–97. https://doi.org/10.1002/jimd.12125.
-
- Siu, VM, Ratko, S, Prasad, AN, Prasad, C, Rupar, CA. Amish microcephaly: long-term survival and biochemical characterization. Am J Med Genet 2010;7:1747–51. https://doi.org/10.1016/10.1002/ajmg.a.33373.
-
- Spiegel, R, Shaag, A, Edvardson, S, Mandel, H, Stepensky, P, Shalev, SA, et al.. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol 2009;66:419–24. https://doi.org/10.1016/10.1002/ana.21752.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials